Abstract:Neuronal apoptosis induced by oxidative stress plays an important role in the pathogenesis and progression of hypoxic-ischemic encephalopathy (HIE). Previous studies reported that activation of melanocortin-1 receptor (MC1R) exerts antioxidative stress, antiapoptotic, and neuroprotective effects in various neurological diseases. However, whether MC1R activation can attenuate oxidative stress and neuronal apoptosis after hypoxic-ischemic- (HI-) induced brain injury remains unknown. Herein, we have investigated the role of MC1R activation with BMS-470539 in attenuating oxidative stress and neuronal apoptosis induced by HI and the underlying mechanisms. 159 ten-day-old unsexed Sprague-Dawley rat pups were used. HI was induced by right common carotid artery ligation followed by 2.5 h of hypoxia. The novel-selective MC1R agonist BMS-470539 was administered intranasally at 1 h after HI induction. MC1R CRISPR KO plasmid and Nurr1 CRISPR KO plasmid were administered intracerebroventricularly at 48 h before HI induction. Percent brain infarct area, short-term neurobehavioral tests, Western blot, immunofluorescence staining, Fluoro-Jade C staining, and MitoSox Staining were performed. We found that the expression of MC1R and Nurr1 increased, peaking at 48 h post-HI. MC1R and Nurr1 were expressed on neurons at 48 h post-HI. BMS-470539 administration significantly attenuated short-term neurological deficits and infarct area, accompanied by a reduction in cleaved caspase-3-positive neurons at 48 h post-HI. Moreover, BMS-470539 administration significantly upregulated the expression of MC1R, cAMP, p-PKA, Nurr1, HO-1, and Bcl-2. However, it downregulated the expression of 4-HNE and Bax, as well as reduced FJC-positive cells, MitoSox-positive cells, and 8-OHdG-positive cells at 48 h post-HI. MC1R CRISPR and Nurr1 CRISPR abolished the antioxidative stress, antiapoptotic, and neuroprotective effects of BMS-470539. In conclusion, our findings demonstrated that BMS-470539 administration attenuated oxidative stress and neuronal apoptosis and improved neurological deficits in a neonatal HI rat model, partially via the MC1R/cAMP/PKA/Nurr1 signaling pathway. Early administration of BMS-470539 may be a novel therapeutic strategy for infants with HIE.

Ryanodine receptor inhibitor dantrolene reduces hypoxic-ischemic brain injury in neonatal mice

Effects of Diazoxide on Μ-Calpain Activation, C-Fos and C-Jun Expres Sion in Neonatal Hypoxic-Ischemic Rat Brain

Dantrolene: effects on abnormal intracellular Ca2+ handling and inotropy in postinfarcted rat myocardium

Activation of ATP-sensitive potassium channels prevents the cleavage of cytosolic ?-calpain and abrogates the elevation of nuclear c-Fos and c-Jun expressions after hypoxic?ischemia in neonatal rat brain

Chronic Dantrolene Treatment Attenuates Cardiac Dysfunction and Reduces Atrial Fibrillation Inducibility in a Rat Myocardial Infarction Heart Failure Model

A novel RyR1-selective inhibitor prevents and rescues sudden death in mouse models of malignant hyperthermia and heat stroke

RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure

RyR2 Stabilizer Attenuates Cardiac Hypertrophy by Downregulating TNF-α/NF-κB/NLRP3 Signaling Pathway through Inhibiting Calcineurin

A Novel Saline-Soluble, Rapidly-Metabolized RyR1 Inhibitor Rescues Volatile Anesthesia-Induced Death and Environmental Heat Stroke in a Mouse Model Relevant to Malignant Hyperthermia

Inhibiting the Interaction Between Apoptosis-Inducing Factor and Cyclophilin A Prevents Brain Injury in Neonatal Mice after Hypoxia-Ischemia.

Dantrolene inhibition of ryanodine receptor 1 carrying the severe malignant hyperthermia mutation Y522S visualized by cryo-EM

Abstract 226: Δ-Opioid Receptor Activation Protects the Brain from Hypoxic-ischemic Injury by Downregulating Inflammatory Cytokines and Upregulating Nrf-2

Dantrolene-induced inhibition of skeletal L-type Ca2+ current requires RyR1 expression

BMS-470539 Attenuates Oxidative Stress and Neuronal Apoptosis via MC1R/cAMP/PKA/Nurr1 Signaling Pathway in a Neonatal Hypoxic-Ischemic Rat Model

Attenuating Ischemic Disruption of K + Homeostasis in the Cortex of Hypoxic-Ischemic Neonatal Rats: DOR Activation Vs. Acupuncture Treatment

Dichloroacetate treatment improves mitochondrial metabolism and reduces brain injury in neonatal mice

Myricitrin attenuates hypoxic-ischemia-induced brain injury in neonatal rats by mitigating oxidative stress and nuclear factor erythroid 2-related factor 2/hemeoxygenase-1/antioxidant response element signaling pathway

Inhibition of Dynamin-Related Protein 1 Has Neuroprotective Effect Comparable with Therapeutic Hypothermia in a Rat Model of Cardiac Arrest.

Lactate administration causes long-term neuroprotective effects following neonatal hypoxia-ischemia

Hypoxic-Ischemic Insult Alters Polyamine and Neurotransmitter Abundance in the Specific Neonatal Rat Brain Subregions

Dantrolene alleviates mitochondrial dysfunction and neuroinflammation in traumatic brain injury by modulating the NF-ĸβ/Akt pathway